DelphX Capital Markets Inc. (TSXV: DELX | OTCQB: DPXCF) has issued a correction to its September 23, 2026 announcement regarding the closing of a non-brokered private placement. The company clarified that it issued 6,400,000 units — not the previously stated 6,100,000 — at C$0.01 per unit, generating aggregate gross proceeds of C$64,000. The correction is material to investors tracking the company's capitalisation and insider participation, as all other terms of the offering remain unchanged.
Key Points
- DelphX Capital Markets Inc. (TSXV: DELX | OTCQB: DPXCF) issued a corrective release on September 24, 2026
- The corrected unit count is 6,400,000 units at C$0.01 per unit, raising C$64,000 in gross proceeds
- Each unit includes one common share and one warrant exercisable at C$0.06 for two years from issuance; an insider subscribed for 500,000 units for C$5,000
- Investors should watch for final TSX Venture Exchange acceptance of the offering and the expiry of the applicable hold period
What the Corrected DelphX Offering Terms Actually State
The original September 23, 2026 release incorrectly stated 6,100,000 units were issued for gross proceeds of C$61,000. The corrected figures confirm 6,400,000 units were sold at C$0.01 each, producing C$64,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at an exercise price of C$0.06 for a period of two years from the date of issuance. No finder's fees were paid in connection with the offering, and all other previously disclosed terms remain in effect as restated.
Insider Participation and Related Party Classification Under MI 61-101
An insider of DelphX participated in the offering, subscribing for 500,000 units for total consideration of C$5,000. This participation classifies the transaction as a related party transaction under Multilateral Instrument 61-101. The company relied on exemptions from formal valuation and minority shareholder approval requirements under sections 5.5(a) and 5.7(1)(a) of MI 61-101, as neither the fair market value of the securities issued nor the cash consideration exceeded 25% of the company's market capitalisation. A material change report was not filed more than 21 days prior to closing, as insider participation was not finalised until shortly before completion.
Use of Proceeds and Exchange Approval Still Pending
DelphX states that net proceeds from the offering will be directed toward working capital and corporate overhead. No proceeds were used to make payments to non-arm's length parties beyond ordinary course business payments, and none were allocated to investor relations activities. Final acceptance of the offering remains subject to TSX Venture Exchange approval. The securities are subject to a statutory hold period of four months plus one day from issuance and, because the units were priced below C$0.05, are additionally subject to the Exchange Hold Period. The immediate share price impact was not clear from available public information.



Please wait processing your request...